Getinge (OTCMKTS:GNGBY) Hits New 52-Week High – What’s Next?

Getinge (OTCMKTS:GNGBY) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $25.22 and last traded at $25.16, with a volume of 4601 shares changing hands. The stock had previously closed at $25.05.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Getinge from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

Getinge Price Performance

The stock has a market capitalization of $6.80 billion, a price-to-earnings ratio of 23.77 and a beta of 0.92. The company has a fifty day simple moving average of $21.71 and a 200 day simple moving average of $21.37. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.74 and a current ratio of 1.31.

Getinge (OTCMKTS:GNGBY) last posted its quarterly earnings data on Friday, July 17th. The company reported $0.38 EPS for the quarter. Getinge had a return on equity of 11.12% and a net margin of 7.81%.The company had revenue of $894.87 million for the quarter. Equities research analysts forecast that Getinge will post 1.38 EPS for the current fiscal year.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.